BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 26
• 27
• 28
• 29

• Drug Development

  MGI PHARMA, INC. And Helsinn Healthcare SA Announce Positive Phase 3 Results For Aloxi(R) (Palonosetron Hydrochloride) Injection For The Prevention Of Post Operative Nausea & Vomiting

  December 14, 2006

   · 

  1 min read
• Policy

  Encysive Pharmaceuticals Says FDA Finds Response To Thelin Incomplete

  December 14, 2006

   · 

  1 min read
• Drug Development

  Cougar Biotechnology Initiates Phase II Trial Of CB7630 (Abiraterone Acetate)

  December 14, 2006

   · 

  1 min read
• Boehringer Ingelheim Corporation Release: Study Shows Dabigatran Etexilate, A New Oral Anticoagulant Is Effective And Safe In Preventing Thromboembolic Disease After Orthopaedic Surgery

  December 14, 2006

   · 

  1 min read
• BioCapital

  Emergent BioSolutions Delivers Over 3 Million Doses Of BioThrax(R) To U.S. Department of Health And Human Services For Strategic National Stockpile

  December 14, 2006

   · 

  1 min read
• Business

  Valeant Pharmaceuticals International And Metabasis Therapeutics, Inc. License Rights To Hepatitis B Compound Pradefovir To Schering-Plough Corporation

  December 14, 2006

   · 

  5 min read
• PrimeGen Biotech Corporation Presents Germ Cell Research At Abcam Stem Cell Conference

  December 14, 2006

   · 

  1 min read
• Business

  OSI Pharmaceuticals, Inc. Grants License To Bristol-Myers Squibb Company Under Dipeptidyl Peptidase IV (DPIV) Patent Portfolio For The Treatment Of Type 2 Diabetes

  December 14, 2006

   · 

  1 min read
• Drug Development

  Biophan Technologies, Inc. Releases Positive Animal Study On MYO-VAD(TM)

  December 14, 2006

   · 

  1 min read
• BioCapital

  Celera Genomics Group-an Applera Corp. Business Identifies Two Genetic Variations Predisposing Individuals To Increased Risk For Psoriasis

  December 14, 2006

   · 

  1 min read